Activity of selpercatinib in RET fusion-positive cancers confirmed
Nature Reviews Clinical Oncology, Published online: 07 October 2022; doi:10.1038/s41571-022-00694-2Activity of selpercatinib in RET fusion-positive cancers confirmed
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Diana Romero Source Type: research
More News: Cancer | Cancer & Oncology